Clinical Trials · NCT06449235
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh
UnknownPhase 4Semaglutide (Unclear)Liraglutide (Unclear)Dulaglutide (Unclear)Exenatide (Unclear)Lixisenatide (Unclear)
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders
- Enrollment
- 938
- Start date
- Sep 2024
- Locations
- 1 site, Bangladesh
- Primary endpoint
- Glycemic Control as Measured by HbA1c Levels